标题
Ticagrelor and Rosuvastatin Have Additive Cardioprotective Effects via Adenosine
作者
关键词
Adenosine, Diabetes mellitus, Infarct size, Ischemia-reperfusion, Ticagrelor, Statin
出版物
CARDIOVASCULAR DRUGS AND THERAPY
Volume 30, Issue 6, Pages 539-550
出版商
Springer Nature
发表日期
2016-11-10
DOI
10.1007/s10557-016-6701-2
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- NLRP3 inflammasome activation during myocardial ischemia reperfusion is cardioprotective
- (2016) Ø. Sandanger et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Inhibition of the NLRP3 inflammasome limits the inflammatory injury following myocardial ischemia–reperfusion in the mouse
- (2016) Stefano Toldo et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Platelet P2Y12Inhibitors Reduce Systemic Inflammation and Its Prothrombotic Effects in an Experimental Human ModelSignificance
- (2015) Mark R. Thomas et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Ticagrelor Protects the Heart Against Reperfusion Injury and Improves Remodeling After Myocardial InfarctionSignificance
- (2015) Yumei Ye et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Statin-Induced Cardioprotection Against Ischemia-Reperfusion Injury: Potential Drug-Drug Interactions. Lesson to be Learnt by Translating Results from Animal Models to the Clinical Settings
- (2015) Gilad D. Birnbaum et al. CARDIOVASCULAR DRUGS AND THERAPY
- NLRP3 inflammasome in peripheral blood monocytes of acute coronary syndrome patients and its relationship with statins
- (2015) Afrasyab Altaf et al. CORONARY ARTERY DISEASE
- Elucidation of novel 13-series resolvins that increase with atorvastatin and clear infections
- (2015) Jesmond Dalli et al. NATURE MEDICINE
- Is immunity a mechanism contributing to statin-induced diabetes?
- (2015) Brandyn D Henriksbo et al. Adipocyte
- Chronic Treatment With Ticagrelor Limits Myocardial Infarct Size
- (2014) Manjyot K. Nanhwan et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- PTEN Upregulation May Explain the Development of Insulin Resistance and Type 2 Diabetes with High Dose Statins
- (2014) Yochai Birnbaum et al. CARDIOVASCULAR DRUGS AND THERAPY
- Statin-Induced Insulin Resistance Through Inflammasome Activation: Sailing Between Scylla and Charybdis
- (2014) Patricia Mitchell et al. DIABETES
- Fluvastatin Causes NLRP3 Inflammasome-Mediated Adipose Insulin Resistance
- (2014) Brandyn D. Henriksbo et al. DIABETES
- 3-Hydroxyl-3-methylglutaryl Coenzyme A (HMG-CoA) Reductase Inhibitor (Statin)-induced 28-kDa Interleukin-1β Interferes with Mature IL-1β Signaling
- (2014) Facundo Davaro et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Characterization of the Adenosine Pharmacology of Ticagrelor Reveals Therapeutically Relevant Inhibition of Equilibrative Nucleoside Transporter 1
- (2014) Duncan Armstrong et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS
- Phosphorylation of 5-Lipoxygenase at Ser523 by Protein Kinase A Determines Whether Pioglitazone and Atorvastatin Induce Proinflammatory Leukotriene B4 or Anti-Inflammatory 15-Epi-Lipoxin A4 Production
- (2014) Y. Ye et al. JOURNAL OF IMMUNOLOGY
- Adenosine-Mediated Effects of Ticagrelor
- (2014) Marco Cattaneo et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- 2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
- (2014) Ezra A. Amsterdam et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Aspirin, Clopidogrel, and Ticagrelor in Acute Coronary Syndromes
- (2013) Jeffrey S. Berger AMERICAN JOURNAL OF CARDIOLOGY
- Exploring the Ticagrelor-Statin Interplay in the PLATO Trial
- (2013) James J. DiNicolantonio et al. CARDIOLOGY
- Rosuvastatin Alleviates Diabetic Cardiomyopathy by Inhibiting NLRP3 Inflammasome and MAPK Pathways in a Type 2 Diabetes Rat Model
- (2013) Beibei Luo et al. CARDIOVASCULAR DRUGS AND THERAPY
- The NLRP3 inflammasome is up-regulated in cardiac fibroblasts and mediates myocardial ischaemia–reperfusion injury
- (2013) Øystein Sandanger et al. CARDIOVASCULAR RESEARCH
- NLRP3 inflammasome activation in coronary artery disease: results from prospective and randomized study of treatment with atorvastatin or rosuvastatin
- (2013) Mamoru Satoh et al. CLINICAL SCIENCE
- Ticagrelor Increases Adenosine Plasma Concentration in Patients With an Acute Coronary Syndrome
- (2013) Laurent Bonello et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Ticagrelor inhibits human platelet aggregation via adenosine in addition to P2Y12antagonism
- (2013) S. Nylander et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Statins and Pulmonary Fibrosis
- (2012) Jin-Fu Xu et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Comparison of cardioprotective efficacy resulting from a combination of atorvastatin and ischaemic post-conditioning in diabetic and non-diabetic rats
- (2012) Ying Fan et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- Novel Aspects of Mevalonate Pathway Inhibitors as Antitumor Agents
- (2012) M. Thurnher et al. CLINICAL CANCER RESEARCH
- Rosuvastatin promotes angiogenesis and reverses isoproterenol-induced acute myocardial infarction in rats: Role of iNOS and VEGF
- (2012) Sawsan A. Zaitone et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Interleukin-1β blockade improves cardiac remodelling after myocardial infarction without interrupting the inflammasome in the mouse
- (2012) Stefano Toldo et al. EXPERIMENTAL PHYSIOLOGY
- HMG-CoA reductase inhibitors activate caspase-1 in human monocytes depending on ATP release and P2X7 activation
- (2012) Y.-H. Liao et al. JOURNAL OF LEUKOCYTE BIOLOGY
- 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction
- (2012) Patrick T. O'Gara et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Deletion of the Innate Immune NLRP3 Receptor Abolishes Cardiac Ischemic Preconditioning and Is Associated with Decreased Il-6/STAT3 Signaling
- (2012) Coert J. Zuurbier et al. PLoS One
- The potential effects of anti-diabetic medications on myocardial ischemia–reperfusion injury
- (2011) Yumei Ye et al. BASIC RESEARCH IN CARDIOLOGY
- Inflammasome Activation of Cardiac Fibroblasts Is Essential for Myocardial Ischemia/Reperfusion Injury
- (2011) Masanori Kawaguchi et al. CIRCULATION
- The inflammasome promotes adverse cardiac remodeling following acute myocardial infarction in the mouse
- (2011) E. Mezzaroma et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Protecting against ischemia-reperfusion injury: antiplatelet drugs, statins, and their potential interactions
- (2010) Yumei Ye et al. Annals of the New York Academy of Sciences
- Dipyridamole with Low-Dose Aspirin Augments the Infarct Size-Limiting Effects of Simvastatin
- (2010) Yumei Ye et al. CARDIOVASCULAR DRUGS AND THERAPY
- Determination of ticagrelor and two metabolites in plasma samples by liquid chromatography and mass spectrometry
- (2010) Henrik Sillén et al. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
- Beneficial effect of rosuvastatin on cardiac dysfunction is associated with alterations in calcium-regulatory proteins
- (2009) Ying Yang et al. EUROPEAN JOURNAL OF HEART FAILURE
- Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
- (2009) Lars Wallentin et al. NEW ENGLAND JOURNAL OF MEDICINE
- The role of eNOS, iNOS, and NF-κB in upregulation and activation of cyclooxygenase-2 and infarct size reduction by atorvastatin
- (2008) Yumei Ye et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Caffeinated Coffee Blunts the Myocardial Protective Effects of Statins against Ischemia–Reperfusion Injury in the Rat
- (2008) Yumei Ye et al. CARDIOVASCULAR DRUGS AND THERAPY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started